1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer: new trials by email Literature Review of Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer trials Research Report on Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） JS001sc (360mg Subcutaneous injection) and pemetrexed/platinum-containing chemotherapy, JS001 (240mg intravenous infusion) and pemetrexed/platinum-containing chemotherapy - Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer | Phase 3 | Active not recruiting | Shanghai Junshi Bioscience Co., Ltd. | 395 | 2024-07-11 | 2025-08-28 |
Infusions, Intravenous (1) · Injections, Subcutaneous (1) · Pemetrexed (1)
Shanghai Junshi Bioscience Co., Ltd. (1)
China (1)